NRAS and breast carcinoma: Transwell and wound healing assays showed that overexpression of NRAS-AS in HepG2 and SMMC-7721 cells resulted in decreased invasiveness and significantly reduced migration capabilities of HCC cells, consistent with findings in breast cancer studies.